Eric Toloza, MD, PhD

Cancer Focus:
Lung Cancer, Mesothelioma, Pancoast Tumor, Thymoma

Dr. Toloza, born in the Philippines and raised in southern California, received his undergraduate degree in 1984 at the University of California, Los Angeles (UCLA). He also received both his medical degree and a Ph.D. from UCLA in 1991. He completed his internship and residency in General Surgery at the University of California, Irvine Medical Center in 1998, during which time he also completed a Surgical Oncology Research Fellowship at UCLA, where he performed gene therapy research for melanoma and sarcoma. He completed his Cardiothoracic Surgery residency in 2000 at the Texas Heart Institute in Houston, TX, where he also completed a concurrent Thoracic Surgical Oncology Fellowship at the University of Texas M.D. Anderson Cancer Center. A Diplomat of the American Board of Surgery, and the American Board of Thoracic Surgery, Dr. Toloza began his practice in 2000 as a Cardiothoracic Surgeon at the Duke University Medical Center in Durham, NC, where he was an Assistant Professor of Surgery. In 2010, Dr. Toloza came to the H. Lee Moffitt Cancer Center in Tampa, FL, where he practices full-time as a Thoracic Oncologist and is now a Senior Member in the multidisciplinary Thoracic Oncology Program. He also has concurrent appointments as Professor of Surgery and Professor of Oncologic Sciences in the University of South Florida Morsani College of Medicine in Tampa. Dr. Toloza is involved in several lung cancer clinical research programs and has authored or co-authored numerous medical journal articles, book chapters and books. He is involved in the evaluation and aggressive combined-modality treatment of all stages of lung cancer, as well as in the evaluation and treatment of mediastinal and chest wall masses and also pulmonary metastases from a variety of other non-thoracic primary malignancies. He is also one of only a few thoracic surgeons worldwide who is certified to perform robotic-assisted thoracic surgery for primary lung cancer, pulmonary metastases, and mediastinal masses. Dr. Toloza is also certified to perform navigational bronchoscopy in order to diagnose lung nodules minimally invasively and lung cancers at early stages. 

Education & Training

Fellowship:

• UCLA School of Medicine - Medical Scientist Fellow Program
• UCLA School of Medicine - Surgical Oncology
• University of Texas MD Anderson Center - Thoracic Surgical Oncology

Residency:

• Texas Heart Institute - Cardiothoracic Surgery

Medical School:

• UCLA School of Medicine - MD

• Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP. Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med. 2024 Jan.30(1):303. Pubmedid: 37816821. Pmcid: PMC10803254.
• Read M, Nguyen T, Swan K, Arnaoutakis DJ, Dua A, Toloza E, Shames M, Bailey C, Latz CA. Cutdown is Associated with Higher 30-day Unplanned Readmissions and Wound Complications Than Percutaneous Access for EVAR. Ann Vasc Surg. 2024 Apr. Pubmedid: 38599484.
• Sather CL, Yang P, Zhang C, Fitzgibbon MP, Fournier M, Toloza E, Tandon A, Schabath M, Yoder S, Nair VS. Protocol optimization of a targeted sequencing panel for genomic profiling of bronchoalveolar lavage fluid in lung cancer. Cancer Med. 2023 Sep.12(17):17632-17637. Pubmedid: 37587851. Pmcid: PMC10524020.
• Baldonado JJAR, Naffouje SA, Parvathaneni S, Roy E, Toloza EM, Fontaine JP. Outcomes of robotic lobectomy for non-small cell lung cancer in a National Cancer Institute-Comprehensive Cancer Center vs. National Cancer Database. J Thorac Dis. 2023 Oct.15(10):5349-5361. Pubmedid: 37969299. Pmcid: PMC10636448.
• Yuan L, Cai H, An W, Yuan W, Toloza EM, Song Y, An J. Associations between marital quality and the prognosis of breast cancer in young Chinese women: 10.3-year median follow-up. Chin Clin Oncol. 2023 Oct.12(5):51. Pubmedid: 37872116.
• Aboukheir Aboukheir A, Villanueva EQ, Garrett JR, Moodie CC, Tew JR, Toloza EM, Fontaine JP, Baldonado JJAR. Association between the Preoperative Standard Uptake Value (SUV) and Survival Outcomes after Robotic-Assisted Segmentectomy for Resectable Non-Small Cell Lung Cancer (NSCLC). Cancers (Basel). 2023 Nov.15(22). Pubmedid: 38001639. Pmcid: PMC10670906.
• Lee JM, McNamee CJ, Toloza E, Negrao MV, Lin J, Shum E, Cummings AL, Kris MG, Sepesi B, Bara I, Kurtsikidze N, Schulze K, Ngiam C, Chaft JE. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives. J Thorac Oncol. 2023 Nov.18(11):1458-1477. Pubmedid: 37451404.
• Doyle WN, Nguyen D, West WJ, Fiedler CR, Labib KM, Ladehoff L, Dumitriu Carcoana AO, Marek JC, Malavet JA, Moodie CC, Garrett JR, Tew JR, Baldonado JJAR, Fontaine JP, Toloza EM. Changes in Perioperative Outcomes after Robotic-Assisted Pulmonary Lobectomy during the COVID-19 Era. Surg Pract Sci. 2023 Jun.13:100172. Pubmedid: 37139165. Pmcid: PMC10125211.
• Chase CB, Mhaskar R, Fiedler C, West WJ, Varadhan A, Cobb J, Cool S, Fishberger G, Dolorit M, Weeden EE, Strang HE, Nguyen D, Garrett JR, Moodie CC, Fontaine JP, Tew JR, Baldonado JJAR, Toloza EM. Effects of preoperative pulmonary function on perioperative outcomes after robotic-assisted pulmonary lobectomy. Am J Surg. 2023 Jul.226(1):128-132. Pubmedid: 37121787.
• Ash-Rafzadeh H, Chambers TJ, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Surgical Day of Week on Postoperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Cureus. 2023 Feb.15(2):e35379. Pubmedid: 36846643. Pmcid: PMC9949999.
• Dumitriu Carcoana AO, Labib KM, Fiedler CR, Marek JC, Ladehoff LC, West WJ, Malavet JA, Doyle WN, Moodie CC, Garrett JR, Tew JR, Baldonado JJAR, Fontaine JP, Toloza E. A High Preoperative Blood Urea Nitrogen to Serum Albumin Ratio Does Not Predict Worse Outcomes Following the Robotic-Assisted Pulmonary Lobectomy for Lung Cancer. Cureus. 2023 Dec.15(12):e50468. Pubmedid: 38222193. Pmcid: PMC10786433.
• Dutta M, Toloza EM, Nguyen D, Mhaskar R, Fishberger G, Fontaine JP, Baldonado JJAR. Effect of octogenarian status on outcomes after robotic-assisted pulmonary lobectomy for primary lung cancer. Geriatr Oncol. 2023 Apr.14(3):101470. Pubmedid: 36989938.
• Rusch VW, Nicholas A, Patterson GA, Waqar SN, Toloza EM, Haura EB, Raz DJ, Reckamp KL, Merritt RE, Owen DH, Finley DJ, McNamee CJ, Blasberg JD, Garon EB, Mitchell JD, Doebele RC, Baciewicz F, Nagasaka M, Pass HI, Schulze K, Johnson A, Bunn PA, Johnson BE, Kris MG, Kwiatkowski DJ, Wistuba II, Chaft JE, Carbone DP, Lee JM. Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung ca. J Thorac Cardiovasc Surg. 2022 Oct. Pubmedid: 36369159.
• Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP. Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med. 2022 Oct.28(10):2155-2161. Pubmedid: 36097216. Pmcid: PMC9556329.
• Rogers MP, Janjua H, Eguia E, Lozonschi L, Toloza EM, Kuo PC. Adopting robotic thoracic surgery impacts hospital overall lung resection case volume. Am J Surg. 2022 Mar.223(3):571-575. Pubmedid: 34844730.
• Rogers MP, Janjua HM, Eguia E, Lozonschi L, Toloza EM, Kuo PC. Embracing future technology: Evaluating the impact of robotic thoracic surgery on hospital systems. Am J Surg. 2022 Mar.223(3):576. Pubmedid: 35184814.
• Jermihov A, Chen L, Echavarria MF, Ng EP, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Socio-Economic Status on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Cureus. 2022 Jun.14(6):e26201. Pubmedid: 35754434. Pmcid: PMC9224841.
• Mullinax JE, Egger ME, McCarter M, Monk BJ, Toloza EM, Brousseau S, Jagasia M, Sarnaik A. Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. Cancer J. 2022 Jul.28(4):285-293. Pubmedid: 35880938. Pmcid: PMC9335895.
• Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2022 Jan.113(1):e29-e31. Pubmedid: 33794166.
• Rogers MP, Janjua H, Fishberger G, Harish A, Sujka J, Toloza EM, DeSantis AJ, Hooker RL, Pietrobon R, Lozonschi L, Kuo PC. A machine learning approach to high-risk cardiac surgery risk scoring. J Card Surg. 2022 Dec.37(12):4612-4620. Pubmedid: 36345692.
• Kulkarni S, Chen L, Jermihov A, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Distance of Residence From the Cancer Center Influences Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy?. Cureus. 2022 Aug.14(8):e28646. Pubmedid: 36158383. Pmcid: PMC9495283.
• Jermihov A, Tsalatsanis A, Kulkarni S, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Lowest Postoperative Pre-albumin on Outcomes after Robotic-Assisted Pulmonary Lobectomy. JSLS. 2021 Jul.25(3). Pubmedid: 34483640. Pmcid: PMC8397293.
• Parvathaneni S, Penafiel M, Garrett J, Toloza E, Fontaine J. Intrathoracic gastric volvulus complicating a robotic left upper lobectomy: A case report and review of literature. Int J Surg Case Rep. 2021 Jan.78:110-115. Pubmedid: 33333353. Pmcid: PMC7749293.
• Creelan BC, Wang C, Teer JK, Toloza EM, Yao J, Kim S, Landin AM, Mullinax JE, Saller JJ, Saltos AN, Noyes DR, Montoya LB, Curry W, Pilon-Thomas SA, Chiappori AA, Tanvetyanon T, Kaye FJ, Thompson ZJ, Yoder SJ, Fang B, Koomen JM, Sarnaik AA, Chen DT, Conejo-Garcia JR, Haura EB, Antonia SJ. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nat Med. 2021 Aug.27(8):1410-1418. Pubmedid: 34385708. Pmcid: PMC8509078.
• Mohamed AZ, Khalil FK, Toloza EM, Tanvetyanon T. Metastasectomy for Isolated Right-Sided Thoracic Lymph Node Metastasis From Tubal Carcinoma. Am Surg. 2020 May.86(5):521-523. Pubmedid: 32684038.
• Folch EE, Mahajan AK, Oberg CL, Maldonado F, Toloza E, Krimsky WS, Oh S, Bowling MR, Benzaquen S, Kinsey CM, Mehta AC, Fernandez-Bussy S, Flandes J, Lau K, Krishna G, Nead MA, Herth F, Aragaki-Nakahodo AA, Barisione E, Bansal S, Zanchi D, Zgoda M, Lutz PO, Lentz RJ, Parks C, Salio M, Perret K, Keyes C, LeMense GP, Hinze JD, Majid A, Christensen M, Kazakov J, Labarca G, Waller E, Studnicka M, Teba CV, Khandhar SJ. Standardized Definitions of Bleeding After Transbronchial Lung Biopsy: A Delphi Consensus Statement From the Nashville Working Group. Chest. 2020 Jul.158(1):393-400. Pubmedid: 32067944. Pmcid: PMC7403751.
• Mumtaz H, Khalil F, Tandon A, Toloza E, Fontaine JP. Primary bronchial Ewing sarcoma. Int J Surg Case Rep. 2019 Jul.61:230-233. Pubmedid: 31377551. Pmcid: PMC6698311.
• Deol PS, Sipko J, Kumar A, Tsalatsanis A, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer. Surgery. 2019 Aug.166(2):211-217. Pubmedid: 31202473.
• Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Reply to Dickhoff et al. from authors of 'Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer'. Lung Cancer. 2018 Oct.124:322-323. Pubmedid: 30193907.
• Michael CW, Faquin W, Jing X, Kaszuba F, Kazakov J, Moon E, Toloza E, Wu RI, Moreira AL. Committee II: Guidelines for cytologic sampling techniques of lung and mediastinal lymph nodes. Diagn Cytopathol. 2018 Oct.46(10):815-825. Pubmedid: 30195266.
• Veronesi G, Park B, Cerfolio R, Dylewski M, Toker A, Fontaine JP, Hanna WC, Morenghi E, Novellis P, Velez-Cubian FO, Amaral MH, Dieci E, Alloisio M, Toloza EM. Robotic resection of Stage III lung cancer: an international retrospective study. Eur J Cardiothorac Surg. 2018 Nov.54(5):912-919. Pubmedid: 29718155. Pmcid: PMC6454562.
• Baldonado JJAR, Amaral M, Garrett J, Moodie C, Robinson L, Keenan R, Toloza EM, Fontaine JP. Credentialing for robotic lobectomy: what is the learning curve? A retrospective analysis of 272 consecutive cases by a single surgeon. J Robot Surg. 2018 Dec.13(5):663-669. Pubmedid: 30560496.
• Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer. Lung Cancer. 2018 Aug.122:206-213. Pubmedid: 30032833.
• Kass KS, Velez-Cubian FO, Zhang WW, Toosi K, Tanvetyanon T, Rodriguez KL, Thau MR, Garrett JR, Moodie CC, Fontaine JP, Toloza EM. Effect of advanced age on peri-operative outcomes after robotic-assisted pulmonary lobectomy: Retrospective analysis of 287 consecutive cases. Geriatr Oncol. 2017 Mar.8(2):102-107. Pubmedid: 28041970.
• Shenoy R, Nanjappa S, Toloza E, Greene J. Infections Leading to Broncholithiasis: A Case Report and Review of All Causes. Infect Dis Clin Prac. 2017 Jan.25(1):5-8.
• Khandhar SJ, Bowling MR, Flandes J, Gildea TR, Hood KL, Krimsky WS, Minnich DJ, Murgu SD, Pritchett M, Toloza EM, Wahidi MM, Wolvers JJ, Folch EE. Electromagnetic navigation bronchoscopy to access lung lesions in 1,000 subjects: first results of the prospective, multicenter NAVIGATE study. BMC Pulm Med. 2017 Apr.17(1):59. Pubmedid: 28399830. Pmcid: PMC5387322.
• Montané B, Toosi K, Velez-Cubian FO, Echavarria MF, Thau MR, Patel RA, Rodriguez K, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Obesity on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Surg Innov. 2017 Apr.24(2):122-132. Pubmedid: 28128014.
• Velez-Cubian FO, Rodriguez KL, Thau MR, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Efficacy of lymph node dissection during robotic-assisted lobectomy for non-small cell lung cancer: retrospective review of 159 consecutive cases. J Thorac Dis. 2016 Sep.8(9):2454-2463. Pubmedid: 27746997. Pmcid: PMC5059267.
• Garcia-Henriquez N, Toloza EM, Khalil F, Echavarria MF, Garrett JR, Moodie CC, Kaszuba FJ, Fontaine JP. Extensive plastic bronchitis: etiology of a rare condition. J Thorac Dis. 2016 Sep.8(9):E961-E965. Pubmedid: 27747036. Pmcid: PMC5059329.
• Echavarria MF, Cheng A, Velez F, Ng E, Toloza E, Fontaine JP, Moodie C, Garrett J. P1.15: Comparison of Pulmonary Function After Robotic-Assisted Video-Thoracoscopic Lobectomies vs Segmentectomies: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S189-S190. Pubmedid: 27676501.
• Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S195. Pubmedid: 27676508.
• Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.17: Improved Survival for Stage-2 (N1) Pulmonary Adenocarcinoma and Squamous Cell Carcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S191-S192. Pubmedid: 27676503.
• Echavarria MF, Cheng A, Velez F, Ng E, Toloza E, Moodie C, Garrett J, Fontaine JP. P1.16: Comparison of Peri-Operative Outcomes After Robotic-Assisted Video-Thoracoscopic Lobectomies Versus Segmentectomies: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S190-S191. Pubmedid: 27676502.
• Toosi K, Velez-Cubian FO, Glover J, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer. Surgery. 2016 Nov.160(5):1211-1218. Pubmedid: 27665362.
• Nanjappa S, DeClue C, Gajanan G, Pabbathi S, Toloza E, Greene J. Pneumonectomy Complicated by Bronchopleural Fistula and Empyema: A Case Report and Review of Literature. Infect Dis Clin Prac. 2016 Mar.24(2):79-82.
• Velez-Cubian FO, Gabordi RC, Smith PV, Toloza EM. Tumor-to-tumor metastasis: an unusual case of breast cancer metastatic to a solitary fibrous tumor. J Thorac Dis. 2016 Jun.8(6):E374-E378. Pubmedid: 27293861. Pmcid: PMC4885953.
• Velez-Cubian FO, Zhang WW, Rodriguez KL, Thau MR, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of small body habitus on peri-operative outcomes after robotic-assisted pulmonary lobectomy: retrospective analysis of 208 consecutive cases. J Thorac Dis. 2016 Jun.8(6):1245-1249. Pubmedid: 27293843. Pmcid: PMC4885994.
• Robinson LA, Tanvetyanon T, Springett G, Fontaine J, Toloza E, Hodul P, Pimiento JM, Malafa M. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. J Thorac Cardiovasc Surg. 2016 Jul.152(1):75-82. Pubmedid: 27050555.
• Cohen AS, Patek R, Enkemann SA, Johnson JO, Chen T, Toloza E, Vagner J, Morse DL. Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo. Bioconjug Chem. 2016 Feb.27(2):427-438. Pubmedid: 26488422. Pmcid: PMC5524213.
• Echavarria MF, Cheng AM, Velez-Cubian FO, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Robinson LA, Toloza EM. Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy. Am J Surg. 2016 Dec.212(6):1175-1182. Pubmedid: 27823756.
• Glover JR, Velez-Cubian FO, Zhang WW, Toosi K, Tanvetyanon T, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy. J Thorac Dis. 2016 Dec.8(12):3614-3624. Pubmedid: 28149556. Pmcid: PMC5227215.
• Park BJ, Snider JM, Bates NR, Cassivi SD, Jett GK, Sonett JR, Toloza EM. Prospective evaluation of biodegradable polymeric sealant for intraoperative air leaks. J Cardiothorac Surg. 2016 Dec.11(1):168. Pubmedid: 27955681. Pmcid: PMC5154021.
• Ng EP, Velez-Cubian FO, Rodriguez KL, Thau MR, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Surgical outcomes associated with postoperative atrial fibrillation after robotic-assisted pulmonary lobectomy: retrospective review of 208 consecutive cases. J Thorac Dis. 2016 Aug.8(8):2079-2085. Pubmedid: 27621862. Pmcid: PMC4999667.
• Glover J, Velez-Cubian FO, Toosi K, Ng E, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer. J Thorac Dis. 2016 Aug.8(8):2165-2174. Pubmedid: 27621873. Pmcid: PMC4999683.
• Folch EE, Bowling MR, Gildea TR, Hood KL, Murgu SD, Toloza EM, Wahidi MM, Williams T, Khandhar SJ. Design of a prospective, multicenter, global, cohort study of electromagnetic navigation bronchoscopy. BMC Pulm Med. 2016 Apr.16(1):60. Pubmedid: 27113209. Pmcid: PMC4845335.
• Straughan DM, Azoury SC, Bennett RD, Pimiento JM, Fontaine JP, Toloza EM. Robotic-Assisted Esophageal Surgery. Cancer Control. 2015 Jul.22(3):335-339. Pubmedid: 26351890.
• Straughan DM, Fontaine JP, Toloza EM. Robotic-Assisted Videothoracoscopic Mediastinal Surgery. Cancer Control. 2015 Jul.22(3):326-330. Pubmedid: 26351888.
• Velez-Cubian FO, Ng EP, Fontaine JP, Toloza EM. Robotic-Assisted Videothoracoscopic Surgery of the Lung. Cancer Control. 2015 Jul.22(3):314-325. Pubmedid: 26351887.
• Toloza EM, Pow-Sang JM. Applications and Advances in Robotic-Assisted Oncological Surgery: Ready to Dock the 'Bot. Cancer Control. 2015 Jul.22(3):278-279. Pubmedid: 26351882.
• Toloza E, Cheng A, Moodie C, Prowler V, Garrett J. Robotic-Assisted Video-Thoracoscopic Completion Right Pneumonectomy for Recurrent Non-small Cell Lung Cancer After Prior Right Lower Lobectomy: A Case Report. Chest. 2014 Mar.145(3 Suppl):37A. Pubmedid: 24638536.
• Toloza E, Sobky C, Cheng A, Chai C, Smithson I, Brown L, Moodie C, Garrett J, Parsons C, Hodul P, Malafa M. Robotic-assisted video-thoracoscopic closure of pancreatico-pleural fistula: a case report. Chest. 2014 Mar.145(3 Suppl):36A. Pubmedid: 24638364.
• Rodriguez K, Velez-Cubian F, Zhang WW, Tanvetyanon T, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Effects of pulmonary function and of smoking history on perioperative outcomes after robotic-assisted pulmonary lobectomy: retrospective analysis of 201 consecutive patients. Chest. 2014 Mar.145(3 Suppl):48A. Pubmedid: 24638644.
• Velez-Cubian F, Gabordi R, Smith P, Dickinson S, Moodie C, Garrett J, Toloza E. Delayed Presentation of Breast Cancer Metastatic to Solitary Fibrous Tumor of the Lung With Synchronous Contralateral Primary Non-small Cell Lung Cancer: A Case Report. Chest. 2014 Mar.145(3 Suppl):295A. Pubmedid: 24638457.
• Velez-Cubian F, Zhang WW, Rodriguez K, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Efficacy of Lymph Node Dissection During Robotic-Assisted Pulmonary Lobectomy for Non-small Cell Lung Cancer: Retrospective Analysis of 159 Consecutive Cases. Chest. 2014 Mar.145(3 Suppl):56A. Pubmedid: 24638719.
• Toloza E, Rodriguez K, Sobky C, Brown L, Garrett J, Chai C, Moodie C, Bhati R, Mosiello G, Zager J. Interclavicular stabilization with the synthes sternal fixation system after radical manubriectomy: report of 3 cases. Chest. 2014 Mar.145(3 Suppl):35A. Pubmedid: 24638364.
• Toloza E, Sobky C, Pimiento J, Garrett J, Pappas-Politis E, Deneve J, Kim D, Plank D, Smith P, Gonzalez R. Multilevel Costovertebral Reconstruction With the Synthes MatrixRIB Fixation System and Vicryl Mesh After Radical Chest Wall Resection for Sarcoma: A Case Report. Chest. 2014 Mar.145(3 Suppl):34A. Pubmedid: 24638509.
• Toloza E, Cheng A, Coppola D, Shan Y, Moodie C, Garrett J, Krblich D, Tran N, Altiok S, Smith P. Metastatic Non-small Cell Lung Cancer Masquerading as Metastatic Renal Cell Cancer: A Case Report. Chest. 2014 Mar.145(3 Suppl):317A. Pubmedid: 24638364.
• Toloza E, Bendure L, Sobky C, Garrett J, Vohra N, Han D, Kim D, Meredith K. Concurrent robotic-assisted pulmonary lobectomy and robotic-assisted ivor-lewis esophagectomy for synchronous primary lung and esophageal cancers: a case report. Chest. 2014 Mar.145(3 Suppl):38A. Pubmedid: 24638547.
• Harris CL, Toloza EM, Klapman JB, Vignesh S, Rodriguez K, Kaszuba FJ. Minimally invasive mediastinal staging of non-small-cell lung cancer: emphasis on ultrasonography-guided fine-needle aspiration. Cancer Control. 2014 Jan.21(1):15-20. Pubmedid: 24357737.
• Toloza EM. Thoracic inspirations: advances in the diagnosis, staging, and treatment of non-small-cell lung cancer. Cancer Control. 2014 Jan.21(1):4-5. Pubmedid: 24357735.
• Demmy TL, Gu L, Burkhalter JE, Toloza EM, D'Amico TA, Sutherland S, Wang X, Archer L, Veit LJ, Kohman L. Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Ne. 2012 Aug.10(8):975-982. Pubmedid: 22878823. Pmcid: PMC5630261.
• Walsh MD, Bruno AD, Onaitis MW, Erdmann D, Wolfe WG, Toloza EM, Levin LS. The role of intrathoracic free flaps for chronic empyema. Ann Thorac Surg. 2011 Mar.91(3):865-868. Pubmedid: 21353016.
• Tong BC, Hanna J, Toloza EM, Onaitis MW, D'Amico TA, Harpole DH, Burfeind WR. Outcomes of video-assisted thoracoscopic decortication. Ann Thorac Surg. 2010 Jan.89(1):220-225. Pubmedid: 20103240.
• Burfeind WR, Jaik NP, Villamizar N, Toloza EM, Harpole DH, D'Amico TA. A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy. Eur J Cardiothorac Surg. 2010 Apr.37(4):827-832. Pubmedid: 19939695.
• Villamizar NR, Darrabie MD, Burfeind WR, Petersen RP, Onaitis MW, Toloza E, Harpole DH, D'Amico TA. Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg. 2009 Aug.138(2):419-425. Pubmedid: 19619789.
• Burfeind WR, Tong BC, O'Branski E, Herndon JE, Toloza EM, D'Amico TA, Harpole LH, Harpole DH. Quality of life outcomes are equivalent after lobectomy in the elderly. J Thorac Cardiovasc Surg. 2008 Sep.136(3):597-604. Pubmedid: 18805257.
• Brass DM, Hollingsworth JW, Cinque M, Li Z, Potts E, Toloza E, Foster WM, Schwartz DA. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol. 2008 Nov.39(5):584-590. Pubmedid: 18539952. Pmcid: PMC2574529.
• Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep.132(3 Suppl):178S-201S. Pubmedid: 17873168.
• Atkins BZ, Harpole DH, Mangum JH, Toloza EM, D'Amico TA, Burfeind WR. Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. Ann Thorac Surg. 2007 Oct.84(4):1107-1112. Pubmedid: 17888955.
• Toloza EM. Previous tumour as a predictor of risk of developing lung cancer. Thorax. 2007 May.62(5):373-374. Pubmedid: 17468450. Pmcid: PMC2117200.
• Toloza EM, Morse MA, Lyerly HK. Gene therapy for lung cancer. J Cell Biochem. 2006 Sep.99(1):1-22. Pubmedid: 16767697.
• Onaitis MW, Petersen RP, Balderson SS, Toloza E, Burfeind WR, Harpole DH, D'Amico TA. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg. 2006 Sep.244(3):420-425. Pubmedid: 16926568. Pmcid: PMC1856541.
• Riedel RF, Wang X, McCormack M, Toloza E, Montana GS, Schreiber G, Kelley MJ. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol. 2006 Sep.1(7):692-696. Pubmedid: 17409938.
• Lemaire A, Nikolic I, Petersen T, Haney JC, Toloza EM, Harpole DH, D'Amico TA, Burfeind WR. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006 Oct.82(4):1185-1189. Pubmedid: 16996905.
• Toloza EM. Gene therapy for lung cancer. Thorac Surg Clin. 2006 Nov.16(4):397-419, vii. Pubmedid: 17240826.
• Petersen RP, Pham D, Toloza EM, Burfeind WR, Harpole DH, Hanish SI, D'Amico TA. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. Ann Thorac Surg. 2006 Jul.82(1):214-218. Pubmedid: 16798217.
• Toloza EM, D'Amico TA. Targeted therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2005 Oct.17(3):199-204. Pubmedid: 16253823.
• Burfeind WR, D'Amico TA, Toloza EM, Wolfe WG, Harpole DH. Low morbidity and mortality for bronchoplastic procedures with and without induction therapy. Ann Thorac Surg. 2005 Aug.80(2):418-421. Pubmedid: 16039176.
• Lemaire A, Burfeind WR, Toloza E, Balderson S, Petersen RP, Harpole DH, D'Amico TA. Outcomes of tracheobronchial stents in patients with malignant airway disease. Ann Thorac Surg. 2005 Aug.80(2):434-437. Pubmedid: 16039180.
• Toloza EM. Gene therapy for lung cancer. Semin Thorac Cardiovasc Surg. 2005.17(3):205-212. Pubmedid: 16253824.
• Thompson RB, Parsa CJ, van den Bos EJ, Davis BH, Toloza EM, Klem I, Glower DD, Taylor DA. Video-assisted thoracoscopic transplantation of myoblasts into the heart. Ann Thorac Surg. 2004 Jul.78(1):303-307. Pubmedid: 15223449.
• Volmar KE, Sporn TA, Toloza EM, Martinez S, Dodd LG, Xie HB. Giant cell tumor of rib masquerading as thymoma: a diagnostic pitfall in needle core biopsy of the mediastinum. Arch Pathol Lab Med. 2004 Apr.128(4):452-455. Pubmedid: 15043459.
• Harpole LH, Kelley MJ, Schreiber G, Toloza EM, Kolimaga J, McCrory DC. Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest. 2003 Jan.123(1 Suppl):7S-20S. Pubmedid: 12527562.
• Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003 Jan.123(1 Suppl):137S-146S. Pubmedid: 12527573.
• Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003 Jan.123(1 Suppl):157S-166S. Pubmedid: 12527575.
• Toloza EM, Harpole DH. Intraoperative techniques to prevent air leaks. Chest Surg Clin N Am. 2002 Aug.12(3):489-505. Pubmedid: 12469483.
• Toloza EM, Hunt K, Miller AR, McBride W, Lau R, Swisher S, Rhoades K, Arthur J, Choi J, Chen L, Chang P, Chen A, Glaspy J, Economou JS. Transduction of murine and human tumors using recombinant adenovirus vectors. Ann Surg Oncol. 1997 Jan.4(1):70-79. Pubmedid: 8985520.
• Toloza EM, Hunt K, Swisher S, McBride W, Lau R, Pang S, Rhoades K, Drake T, Belldegrun A, Glaspy J, Economou JS. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. Cancer Gene Ther. 1996 Jan-Feb.3(1):11-17. Pubmedid: 8785705.
• Economou JS, Belldegrun AS, Glaspy J, Toloza EM, Figlin R, Hobbs J, Meldon N, Kaboo R, Tso CL, Miller A, Lau R, McBride W, Moen RC. In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial. J Clin Invest. 1996 Jan.97(2):515-521. Pubmedid: 8567975. Pmcid: PMC507045.
• Toloza EM, Diamond J. Ontogenetic development of nutrient transporters in rat intestine. Am J Physiol. 1992 Nov.263(5 Pt 1):G593-G604. Pubmedid: 1443134.
• Toloza EM, Lam M, Diamond J. Nutrient extraction by cold-exposed mice: a test of digestive safety margins. Am J Physiol. 1991 Oct.261(4 Pt 1):G608-G620. Pubmedid: 1928348.
• Coady MJ, Pajor AM, Toloza EM, Wright EM. Expression of mammalian renal transporters in Xenopus laevis oocytes. Arch Biochem Biophys. 1990 Nov.283(1):130-134. Pubmedid: 2241165.
• Toloza EM, Diamond JM. Ontogenetic development of transporter regulation in bullfrog intestine. Am J Physiol. 1990 May.258(5 Pt 1):G770-G773. Pubmedid: 2334002.
• Toloza EM, Diamond JM. Ontogenetic development of nutrient transporters in bullfrog intestine. Am J Physiol. 1990 May.258(5 Pt 1):G760-G769. Pubmedid: 2334001.
• Chang A, Toloza E, Bulinski JC. Changes in the expression of beta and gamma actins during differentiation of PC12 cells. J Neurochem. 1986 Dec.47(6):1885-1892. Pubmedid: 3021908.